320 related articles for article (PubMed ID: 28288136)
1. Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling.
Junk DJ; Bryson BL; Smigiel JM; Parameswaran N; Bartel CA; Jackson MW
Oncogene; 2017 Jul; 36(28):4001-4013. PubMed ID: 28288136
[TBL] [Abstract][Full Text] [Related]
2. STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.
Bryson BL; Junk DJ; Cipriano R; Jackson MW
Cell Cycle; 2017 Feb; 16(4):319-334. PubMed ID: 27892764
[TBL] [Abstract][Full Text] [Related]
3. Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer.
Smigiel JM; Parameswaran N; Jackson MW
Mol Cancer Res; 2017 Apr; 15(4):478-488. PubMed ID: 28053127
[TBL] [Abstract][Full Text] [Related]
4. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
Doherty MR; Parvani JG; Tamagno I; Junk DJ; Bryson BL; Cheon HJ; Stark GR; Jackson MW
Breast Cancer Res; 2019 Apr; 21(1):54. PubMed ID: 31036052
[TBL] [Abstract][Full Text] [Related]
5. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
6. Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition.
Guo L; Chen C; Shi M; Wang F; Chen X; Diao D; Hu M; Yu M; Qian L; Guo N
Oncogene; 2013 Nov; 32(45):5272-82. PubMed ID: 23318420
[TBL] [Abstract][Full Text] [Related]
7. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
[TBL] [Abstract][Full Text] [Related]
8. A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo.
Tiffen PG; Omidvar N; Marquez-Almuina N; Croston D; Watson CJ; Clarkson RW
Mol Endocrinol; 2008 Dec; 22(12):2677-88. PubMed ID: 18927239
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3.
Li Q; Zhu J; Sun F; Liu L; Liu X; Yue Y
Int J Mol Med; 2011 Jul; 28(1):101-8. PubMed ID: 21399864
[TBL] [Abstract][Full Text] [Related]
10. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
[TBL] [Abstract][Full Text] [Related]
11. Smad3-STAT3 crosstalk in pathophysiological contexts.
Itoh Y; Saitoh M; Miyazawa K
Acta Biochim Biophys Sin (Shanghai); 2018 Jan; 50(1):82-90. PubMed ID: 29140406
[TBL] [Abstract][Full Text] [Related]
12. STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling.
Wang G; Yu Y; Sun C; Liu T; Liang T; Zhan L; Lin X; Feng XH
Oncogene; 2016 Aug; 35(33):4388-98. PubMed ID: 26616859
[TBL] [Abstract][Full Text] [Related]
13. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
[TBL] [Abstract][Full Text] [Related]
14. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
15. c-MYC functions as a molecular switch to alter the response of human mammary epithelial cells to oncostatin M.
Kan CE; Cipriano R; Jackson MW
Cancer Res; 2011 Nov; 71(22):6930-9. PubMed ID: 21975934
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin-M-Reactive Pericytes Aggravate Blood-Brain Barrier Dysfunction by Activating JAK/STAT3 Signaling In Vitro.
Takata F; Dohgu S; Sakaguchi S; Sakai K; Yamanaka G; Iwao T; Matsumoto J; Kimura I; Sezaki Y; Tanaka Y; Yamauchi A; Kataoka Y
Neuroscience; 2019 Dec; 422():12-20. PubMed ID: 31705893
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M-induced blood-brain barrier impairment is due to prolonged activation of STAT3 signaling in vitro.
Takata F; Dohgu S; Matsumoto J; Machida T; Sakaguchi S; Kimura I; Yamauchi A; Kataoka Y
J Cell Biochem; 2018 Nov; 119(11):9055-9063. PubMed ID: 30076740
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M and leukaemia inhibitory factor trigger signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2 pathways but result in heterogeneous cellular responses in trophoblast cells.
Chaiwangyen W; Ospina-Prieto S; Morales-Prieto DM; Pereira de Sousa FL; Pastuschek J; Fitzgerald JS; Schleussner E; Markert UR
Reprod Fertil Dev; 2016 Apr; 28(5):608-17. PubMed ID: 25247600
[TBL] [Abstract][Full Text] [Related]
19. JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.
Shien K; Papadimitrakopoulou VA; Ruder D; Behrens C; Shen L; Kalhor N; Song J; Lee JJ; Wang J; Tang X; Herbst RS; Toyooka S; Girard L; Minna JD; Kurie JM; Wistuba II; Izzo JG
Mol Cancer Ther; 2017 Oct; 16(10):2234-2245. PubMed ID: 28729401
[TBL] [Abstract][Full Text] [Related]
20. Induction of STAT3-Dependent CXCL5 Expression and Neutrophil Recruitment by Oncostatin-M during Pneumonia.
Traber KE; Hilliard KL; Allen E; Wasserman GA; Yamamoto K; Jones MR; Mizgerd JP; Quinton LJ
Am J Respir Cell Mol Biol; 2015 Oct; 53(4):479-88. PubMed ID: 25692402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
